Trust

    Editorial Policy

    How Second Look Cancer creates patient-facing content, updates public pages, and keeps educational material distinct from medical advice.

    Reviewed by Second Look Cancer
    Last reviewed: April 2026

    Our editorial goal

    We aim to make clinical trial information more readable, more honest about uncertainty, and more useful for real patient decision-making.

    That means favoring clear explanations, practical tradeoffs, and terminology patients can act on in conversations with their care team.

    What we optimize for

    Pages are written to help colorectal cancer patients understand what a topic means, why it matters, and what to ask next.

    We avoid presenting educational content as individualized medical advice, and we try to make the limits of the information clear.

    How updates are handled

    When major public pages are revised, we review for factual alignment, clarity, and consistency with the trust materials on this site.

    Content may be refreshed as product capabilities, public trial records, or patient education needs evolve.

    Related reading